清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Short-Term Outcome and Morbidity of Different Contemporary Urethroplasty Techniques—A Preliminary Comparison

尿道成形术 医学 尿道狭窄 比例危险模型 外科 危险系数 队列 不利影响 内科学 尿道 置信区间
作者
Luis A. Kluth,Roland Dahlem,Philip T. Reiss,Daniel Pfalzgraf,Andreas Becker,Oliver Engel,Felix K.‐H. Chun,Margit Fisch,Sascha Ahyai
出处
期刊:Journal of Endourology [Mary Ann Liebert, Inc.]
卷期号:27 (7): 925-929 被引量:20
标识
DOI:10.1089/end.2013.0029
摘要

Background and Purpose: Only few comparative reports about different urethroplasties have been published, addressing success rate (SR), adverse events (AE), and quality of life (QoL). Our purpose was to evaluate SR, AE, and QoL in a contemporary cohort of patients undergoing urethroplasty in the short-term follow-up (FU). Patients and Methods: Between December 2008 and June 2010, 205 patients underwent urethroplasty for anterior urethral strictures at our institution. A standardized questionnaire was sent to all patients. The primary end point was SR. Secondary end points were AE and QoL. To assess the risk of SR, the Kaplan-Meier method and log-rank test were used. To assess risk factors for urethral stricture recurrence (SRec), univariable Cox regression analysis was used. Results: Overall, 140 (68%) patients responded to our questionnaire and were used for analysis. Of these 9%, 85%, and 6% were treated by excision and primary anastomosis (EPA), buccal mucosa graft urethroplasty (BMGU), and mesh graft urethroplasty (MGU), respectively. At 10 months of FU, SR was 87.5%. SRs of EPA, BMGU, and MGU were 100% (n=13/13), 85.7% (n=102/119), and 87.5% (n=7/8), with no significant differences between the groups. In univariable analysis, ≥2 vs 1 previous urethroplasties showed a trend toward a reduced SR (hazard risk 2.95; P=0.057). Streaking the urethra (P=0.024) and penile curvature (P=0.026) were significantly more often associated with MGU compared with EPA and BMGU. Postoperative total median (mean) scores were 3.5 (4.8) for the International Consultation on Incontinence Questionnaire Male lower urinary tract symptoms, 15 (15.2) for the International Index of Erectile Function, and 80 (73) for EuroQol visual analogue score; there was no difference between urethroplasty types. Conclusion: In the short-term FU, urethroplasty demonstrates an excellent SR. Specific SRs of EPA, BMGU, and MGU seem comparable. Despite significant differences in AE, patient reported QoL is high with no difference between the applied techniques.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
5秒前
Charming完成签到,获得积分10
6秒前
Charming发布了新的文献求助10
11秒前
1分钟前
zsyf发布了新的文献求助10
1分钟前
Kinkin完成签到,获得积分10
1分钟前
DarknessDuck发布了新的文献求助10
1分钟前
纪靖雁完成签到 ,获得积分10
1分钟前
zsyf完成签到,获得积分10
1分钟前
molihuakai应助DarknessDuck采纳,获得10
1分钟前
2分钟前
谢锦印完成签到,获得积分10
2分钟前
2分钟前
谢锦印发布了新的文献求助10
2分钟前
欣欣发布了新的文献求助10
2分钟前
mzhang2完成签到 ,获得积分10
2分钟前
玩命的寄翠完成签到 ,获得积分10
2分钟前
勤劳觅风完成签到,获得积分10
2分钟前
儒雅的夏翠完成签到,获得积分10
2分钟前
呆萌如容完成签到,获得积分10
2分钟前
科研通AI2S应助铭铭采纳,获得10
4分钟前
胡萝卜完成签到,获得积分10
4分钟前
4分钟前
铭铭发布了新的文献求助10
4分钟前
香蕉觅云应助铭铭采纳,获得10
5分钟前
标致的满天完成签到 ,获得积分10
5分钟前
Phiephie发布了新的文献求助10
5分钟前
5分钟前
铭铭发布了新的文献求助10
5分钟前
机灵自中完成签到,获得积分10
5分钟前
Seriously完成签到,获得积分10
6分钟前
FashionBoy应助铭铭采纳,获得10
6分钟前
欣喜的香菱完成签到 ,获得积分10
6分钟前
Cm666应助Xenomorph采纳,获得10
6分钟前
桐桐应助科研通管家采纳,获得10
6分钟前
Orange应助科研通管家采纳,获得10
6分钟前
6分钟前
6分钟前
铭铭发布了新的文献求助10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics 500
A Social and Cultural History of the Hellenistic World 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6394582
求助须知:如何正确求助?哪些是违规求助? 8209714
关于积分的说明 17382316
捐赠科研通 5447800
什么是DOI,文献DOI怎么找? 2880027
邀请新用户注册赠送积分活动 1856542
关于科研通互助平台的介绍 1699160